drospirenone has been researched along with Venous Thrombosis in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 8 (50.00) | 29.6817 |
| 2010's | 8 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lidegaard, Ø | 1 |
| Colli, E; Palacios, S; Regidor, PA | 1 |
| Abenhaim, HA; Eisenberg, MJ; Filion, KB; Grandi, SM; Joseph, L; Wu, CQ | 1 |
| de Bastos, M; Dekkers, OM; Helmerhorst, FM; Rosendaal, FR; Stegeman, BH; Stijnen, T; Van Hylckama Vlieg, A | 1 |
| Gronich, N; Lavi, I; Rennert, G | 1 |
| Solymoss, S | 1 |
| van Grootheest, K; Vrieling, T | 1 |
| Goldzieher, JW; Shulman, LP | 1 |
| Dinger, J; Heinemann, LA | 1 |
| Ardito, R; Cammarota, A; Di Renzo, N; Gallucci, G; Romano, G; Tartarone, A | 1 |
| Aznar, J; Contreras, T; Ferrando, F; Mira, Y; Morata, C; Vayá, A | 1 |
| Gold, MA; Kaizar, EE; Kelleher, KJ; O'Brien, SH | 1 |
| Sheldon, T | 1 |
4 review(s) available for drospirenone and Venous Thrombosis
| Article | Year |
|---|---|
Drospirenone-containing oral contraceptive pills and the risk of venous and arterial thrombosis: a systematic review.
Topics: Androstenes; Arteries; Contraceptives, Oral, Hormonal; Female; Humans; Myocardial Infarction; Pulmonary Embolism; Risk; Stroke; Thrombosis; Venous Thromboembolism; Venous Thrombosis | 2013 |
Combined oral contraceptives: venous thrombosis.
Topics: Androstenes; Contraceptives, Oral, Combined; Cyproterone; Desogestrel; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Norpregnenes; Pulmonary Embolism; Randomized Controlled Trials as Topic; Venous Thrombosis | 2014 |
The truth about oral contraceptives and venous thromboembolism.
Topics: Androstenes; Bias; Confounding Factors, Epidemiologic; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Desogestrel; Female; Humans; Risk Factors; Thromboembolism; Time Factors; Venous Thrombosis; Women's Health | 2003 |
Safety of a new oral contraceptive containing drospirenone.
Topics: Adult; Androstenes; Clinical Trials as Topic; Contraceptives, Oral; Female; Humans; Hyperkalemia; Mineralocorticoid Receptor Antagonists; Risk Factors; Venous Thrombosis | 2004 |
1 trial(s) available for drospirenone and Venous Thrombosis
| Article | Year |
|---|---|
Multicenter, phase III trials on the contraceptive efficacy, tolerability and safety of a new drospirenone-only pill.
Topics: Adult; Androstenes; Contraceptives, Oral; Female; Humans; Hyperkalemia; Metrorrhagia; Pregnancy; Pregnancy Rate; Prospective Studies; Pulmonary Embolism; Treatment Failure; Venous Thrombosis; Young Adult | 2019 |
11 other study(ies) available for drospirenone and Venous Thrombosis
| Article | Year |
|---|---|
Severely biased review of studies assessing the risk of venous thrombosis in users of drospirenone-containing oral contraceptives.
Topics: Androstenes; Contraceptives, Oral, Combined; Female; Humans; Venous Thromboembolism; Venous Thrombosis | 2018 |
Drospirenone: high risk of venous thrombosis.
Topics: Androstenes; Contraceptives, Oral, Combined; Dose-Response Relationship, Drug; Ethinyl Estradiol; Female; Humans; Venous Thrombosis | 2011 |
Higher risk of venous thrombosis associated with drospirenone-containing oral contraceptives: a population-based cohort study.
Topics: Adolescent; Adult; Androstenes; Child; Contraceptives, Oral, Combined; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Incidence; Israel; Middle Aged; Mineralocorticoid Receptor Antagonists; Population Surveillance; Progesterone Congeners; Prognosis; Venous Thrombosis; Young Adult | 2011 |
Risk of venous thromboembolism with oral contraceptives.
Topics: Androstenes; Contraceptives, Oral, Combined; Female; Humans; Population Surveillance; Venous Thrombosis | 2011 |
Drospirenone: venous thrombosis (continued).
Topics: Androstenes; Contraceptives, Oral, Combined; Humans; Venous Thrombosis | 2012 |
Thromboembolism associated with the new contraceptive Yasmin.
Topics: Adolescent; Adult; Androstenes; Contraceptives, Oral, Combined; Fatal Outcome; Female; Humans; Middle Aged; Mineralocorticoid Receptor Antagonists; Pulmonary Embolism; Thromboembolism; Venous Thrombosis | 2003 |
Venous thromboembolism after high-dose chemotherapy in a patient with Hodgkin's lymphoma receiving the new oral contraceptive ethinylestradiol and drospirenone ("Yasmine").
Topics: Adult; Androstenes; Angiography; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Contraceptives, Oral, Synthetic; Cytarabine; Etoposide; Female; Hodgkin Disease; Humans; Immunotherapy; International Normalized Ratio; Lynestrenol; Melphalan; Mineralocorticoid Receptor Antagonists; Risk; Risk Factors; Time Factors; Venous Thrombosis; Warfarin | 2005 |
Is Yasmin as safe as other contraceptive pills?
Topics: Adult; Androstenes; Contraceptive Agents; Edema; Female; Humans; Pain; Venous Thrombosis | 2006 |
Trends in prescribing patterns of hormonal contraceptives for adolescents.
Topics: Administration, Cutaneous; Administration, Oral; Adolescent; Adult; Androstenes; Child; Contraceptives, Oral, Combined; Desogestrel; Drug Prescriptions; Female; Humans; Practice Patterns, Physicians'; Risk Factors; United States; Venous Thrombosis | 2008 |
Dutch GPs warned against new contraceptive pill.
Topics: Adolescent; Androstenes; Contraceptives, Oral; Drug and Narcotic Control; Europe; Family Practice; Female; Humans; Risk; Venous Thrombosis | 2002 |
Yasmin--an oral contraceptive with a new progestin.
Topics: Acne Vulgaris; Androstenes; Body Weight; Contraceptive Agents; Contraceptives, Oral, Combined; Female; Humans; Mineralocorticoid Receptor Antagonists; Progesterone Congeners; Progestins; Thromboembolism; Venous Thrombosis; Weight Gain | 2002 |